Approved in June 2017 by the U.S. Food and Drug Administration and launched commercially in-country in October 2018, 5-Aminolevulinic Acid (also known as 5-ALA, and composed of aminolevulinic acid hydrochloride) is an optical imaging agent for use in patients with high-grade gliomas. Nicknamed the “pink drink,” 5-ALA is a surgical…...
While recent medical discoveries, from drugs to imaging techniques, continue to revolutionize cancer care, none of them would be possible without foundations having been laid years, or even decades, earlier. Groundbreaking work by the late endocrinologist Jack Gorski, Ph.D., who passed away in 2006 and was funded by the National…...
Brain cancer is a formidable adversary in the world of oncology. Against substantial odds, patients work with dedicated doctors to mount a counter offensive. The road to recovery is, to no one’s astonishment, arduous, as brain surgery exposes the very epicenter of our being, behavior, personality, motor skills and memory.…...
The effectiveness of certain chemotherapy drugs may be reduced by fat cells. This groundbreaking recent discovery was made according to a recent study published in November 2017 in Molecular Cancer Research, a journal of the American Association for Cancer Research. Obesity has long been associated with a higher risk of…...
The mental status of cancer survivors can be fragile and destabilized. Psycho-social complications often arise, such as fear of recurrent illness, financial hardship, anxiety, difficulty handling the end of treatment, fatigue, lasting “brain fog”, broken relationships and even post-traumatic stress disorder. In order to navigate this myriad of challenging issues…...
It is estimated that by the year 2030, deaths due to cancer will drop dramatically and life expectancy after diagnosis will have significantly increased. Whereas this is encouraging news and proof positive that the practice of oncology and the drugs used to treat cancer have become progressively more effective, there…...
Researchers have ascertained that the anti-tapeworm drug, nitazoxanide (NTZ), may also hold out hope as a precision therapy for various cancers. Prostate and colon cancer cells contain high amounts of activated beta-catenin, which correlate to treatment-resistant cancer cells and other oncological parameters. In a study of the cancer-abetting potential of…...
Free Cancer Screening Guidelines
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
5515 Security Lane, Suite 1105 Rockville, MD 20852
